Thomas D. Walters

20.9k total citations · 2 hit papers
116 papers, 5.4k citations indexed

About

Thomas D. Walters is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Thomas D. Walters has authored 116 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 54 papers in Epidemiology and 50 papers in Surgery. Recurrent topics in Thomas D. Walters's work include Inflammatory Bowel Disease (74 papers), Microscopic Colitis (46 papers) and Adolescent and Pediatric Healthcare (17 papers). Thomas D. Walters is often cited by papers focused on Inflammatory Bowel Disease (74 papers), Microscopic Colitis (46 papers) and Adolescent and Pediatric Healthcare (17 papers). Thomas D. Walters collaborates with scholars based in Canada, United States and Israel. Thomas D. Walters's co-authors include Anne M. Griffiths, Dan Turner, Jeffrey S. Hyams, James Markowitz, Anthony Otley, Arie Levine, Mary Sherlock, Frank M. Ruemmele, Mary Zachos and David R. Mack and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Stroke.

In The Last Decade

Thomas D. Walters

113 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pediatric modification of the Montreal classification for inflammatory bowel disease

2010 1.1k citations Arie Levine, Anne M. Griffiths et al. Inflammatory Bowel Diseases profile →
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study

2007 788 citations Dan Turner, Anthony Otley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas D. Walters Canada	35	3.7k	2.8k	1.8k	1.0k	492	116	5.4k
Johanna C. Escher Netherlands	40	4.0k 1.1×	2.7k 1.0×	2.2k 1.3×	1.2k 1.1×	611 1.2×	164	6.9k
Arie Levine Israel	41	5.0k 1.4×	3.5k 1.3×	2.9k 1.7×	998 1.0×	340 0.7×	150	7.5k
George D. Ferry United States	33	3.3k 0.9×	2.2k 0.8×	1.7k 1.0×	806 0.8×	658 1.3×	100	5.4k
G. Veereman‐Wauters Belgium	25	2.1k 0.6×	1.6k 0.6×	1.3k 0.8×	595 0.6×	342 0.7×	60	4.1k
Subra Kugathasan United States	47	5.1k 1.4×	3.4k 1.2×	2.2k 1.2×	1.7k 1.7×	575 1.2×	175	7.8k
James Markowitz United States	41	5.7k 1.5×	4.2k 1.5×	2.3k 1.3×	1.4k 1.4×	744 1.5×	121	7.3k
Lissy de Ridder Netherlands	30	2.3k 0.6×	1.5k 0.5×	1.3k 0.7×	792 0.8×	313 0.6×	124	3.4k
Adam S. Cheifetz United States	49	4.9k 1.3×	3.6k 1.3×	1.9k 1.1×	2.3k 2.2×	126 0.3×	213	7.7k
Maria Oliva‐Hemker United States	36	1.8k 0.5×	1.4k 0.5×	1.0k 0.6×	458 0.4×	312 0.6×	94	3.5k
Joel R. Rosh United States	32	2.4k 0.6×	1.7k 0.6×	1.0k 0.6×	648 0.6×	350 0.7×	137	3.9k

Countries citing papers authored by Thomas D. Walters

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Walters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Walters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Walters more than expected).

Fields of papers citing papers by Thomas D. Walters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Walters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Walters. The network helps show where Thomas D. Walters may publish in the future.

Co-authorship network of co-authors of Thomas D. Walters

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Walters. A scholar is included among the top collaborators of Thomas D. Walters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Walters. Thomas D. Walters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuenzig, M Ellen, Thomas D. Walters, David Mack, et al.. (2024). High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative Data. Inflammatory Bowel Diseases. 31(4). 1018–1031. 2 indexed citations

Chami, Rose, et al.. (2024). Myointimal hyperplasia of the mesenteric veins mimicking inflammatory bowel disease in a 13‐year‐old patient. JPGN Reports. 5(4). 491–496. 1 indexed citations

Geem, Duke, David M. Hercules, Suresh Venkateswaran, et al.. (2023). Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. Clinical Gastroenterology and Hepatology. 22(2). 368–376.e4. 9 indexed citations

Walters, Thomas D., et al.. (2023). A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 6(2). 73–79. 3 indexed citations

Walters, Thomas D., et al.. (2023). A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease. Quality of Life Research. 32(9). 2527–2539. 3 indexed citations

Frost, Karen, Luca Scarallo, Eric I. Benchimol, et al.. (2023). Body Surface Area-Based Dosing of Infliximab is Superior to Standard Weight-Based Dosing in Children With Very Early Onset Inflammatory Bowel Disease. SHILAP Revista de lepidopterología. 3(2). 215–220. 4 indexed citations

Rinawi, Firas, Mary‐Louise C. Greer, Thomas D. Walters, et al.. (2022). Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?. Journal of Pediatric Surgery. 57(11). 569–574. 4 indexed citations

Kohut, Sara Ahola, et al.. (2021). Online Acceptance and Commitment Therapy and Nutrition Workshop for Parents of Children with Inflammatory Bowel Disease: Feasibility, Acceptability, and Initial Effectiveness. Children. 8(5). 396–396. 8 indexed citations

Aardoom, M, Polychronis Kemos, Irma Tindemans, et al.. (2020). International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open. 10(7). e035538–e035538. 9 indexed citations

10.

Ricciuto, Amanda, Bettina E. Hansen, Marina Aloi, et al.. (2019). Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment. Clinical Gastroenterology and Hepatology. 18(7). 1509–1517.e7. 22 indexed citations

11.

Carman, Nicholas, Peter Church, David Mack, et al.. (2018). Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn’s disease. Gastrointestinal Endoscopy. 89(2). 364–372. 28 indexed citations

12.

Carman, Nicholas, Rahim Moineddin, Sebastian K. King, et al.. (2017). Can MR enterography screen for perianal disease in pediatric inflammatory bowel disease?. Journal of Magnetic Resonance Imaging. 47(6). 1638–1645. 9 indexed citations

13.

Ricciuto, Amanda, Binita M. Kamath, Thomas D. Walters, et al.. (2017). New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children. The Journal of Pediatrics. 194. 128–135.e1. 13 indexed citations

14.

Navas‐López, Víctor Manuel, Javier Martín‐de‐Carpi, Amy Grant, et al.. (2016). P113. Quality of life in paediatric Crohn’s disease: data from the Imagekids study. Journal of Crohn s and Colitis. 10(suppl 1). S145–S146. 1 indexed citations

15.

Church, Peter, Thomas D. Walters, Karen Frost, et al.. (2014). Infliximab Maintains Durable Response and Facilitates Catch-up Growth in Luminal Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases. 20(7). 1177–1186. 67 indexed citations

16.

Elkadri, Abdul, Joanne M. Stempak, Thomas D. Walters, et al.. (2013). Serum Antibodies Associated with Complex Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(7). 1499–1505. 27 indexed citations

17.

Levine, Arie, Anne M. Griffiths, James Markowitz, et al.. (2010). Pediatric modification of the Montreal classification for inflammatory bowel disease. Inflammatory Bowel Diseases. 17(6). 1314–1321. 1054 indexed citations breakdown →

18.

Bartlett, Eric, Thomas D. Walters, Sean Symons, Richard I. Aviv, & Allan J. Fox. (2008). Classification of Carotid Stenosis by Millimeter CT Angiography Measures: Effects of Prevalence and Gender. American Journal of Neuroradiology. 29(9). 1677–1683. 14 indexed citations

19.

Muise, Aleixo M., Thomas D. Walters, Eytan Wine, et al.. (2007). Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis. Current Biology. 17(14). 1212–1218. 50 indexed citations

20.

Walters, Thomas D., Ashley Gilman, & Anne M. Griffiths. (2006). Linear Growth Improves during Infliximab Therapy in Children with Chronically Active Severe Crohnʼs Disease. Inflammatory Bowel Diseases. 13(4). 424–430. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact